Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.

  1. A new biomarker for diabetic foot ulcers

    SBC: Noveratech LLC            Topic: 100

    DESCRIPTION provided by applicant This proposal is submitted in response to the new NIDDK announcement PA calling for development of methodologies or biomarkers to help understand the pathophysiology of T D type diabetes T D complications An estimated of the million diabetic patients in this country will develop diabetic foot ulcers DFU at some point in their lives ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  2. A new technique for diabetic foot ulcers

    SBC: Noveratech LLC            Topic: 200

    DESCRIPTION provided by applicant This proposal is submitted in response to the new NIDDK announcement PA calling for development of new diagnostic monitoring and therapeutics technologies for the complications of type diabetes T D An estimated of the million diabetic patients in this country will develop diabetic foot ulcers DFU at some point in their lives Curr ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. A New Technique for Diabetic Foot Ulcers

    SBC: Noveratech LLC            Topic: 200

    ABSTRACT Diabetes is the leading cause of nontraumatic lower extremity amputations in the United States Diabetic foot ulcers DFUs are responsible for more hospitalizations than any other diabetic complications Currently even the best available treatments achieve only a healing rate for these wounds and this healing is often only temporary with a chance of recurring Our company has ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. A non surgical embryo transfer device for producing gene modified rats

    SBC: PARATECHS CORP.            Topic: 200

    DESCRIPTION provided by applicant ParaTechs Corporation develops innovative technologies for biomedical research while seeking to improve animal welfare for laboratory animals One of ParaTechsandapos major goals is to further the guiding principles of ethical animal use by andapos reducing replacing and refiningandapos the use of animals in research according to the guidelines of Russell a ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. A novel biomarker of infection in neutropenic cancer patients

    SBC: BIOPOWERTECH            Topic: NIAID

    DESCRIPTION provided by applicant Early diagnosis of an infection in neutropenic cancer patients is critical for timely treatment But the diagnosis of an infection in these patients especially at an early stage can be very challenging Therefore there is a great need for sensitive biomarkers that can rapidly predict an infection and provide possible outcomes We have already reported that s ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. A novel phosphodiesterase isozyme target and class of inhibitors for lung cancer

    SBC: ADT Pharmaceuticals, LLC            Topic: 102

    DESCRIPTION provided by applicant Lung cancer causes more deaths in men and women than any other cancer in the United States Late detection of disease and inability to effectively treat this malignancy with chemotherapy are the main reasons for low survival rates There is an urgent medical need to develop new molecularly targeted drugs for treating lung cancer although it has been challengin ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Adiponectin Secretion Enhancer Synthetic Organic Drug Discovery and Development

    SBC: DISCOVERYBIOMED, INC.            Topic: 200

    DESCRIPTION provided by applicant DiscoveryBioMed Inc DBM completed recently Phase I SBIR funded goals milestones specific experimental aims and efforts to screen synthetic organic small molecules on immortalized and primary differentiated human adipocyte platforms and to validate the high throughput screening HTS based Drug Discovery output with a Critical Path of bioassays dete ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. A mechanism based computational tool to optimize pulmonary drug delivery

    SBC: CFD Research Corporation            Topic: 300

    DESCRIPTION provided by applicant Pulmonary drug delivery has emerged as a noninvasive alternative route for the treatment of lung diseases asthma COPD CF and lung cancer In order to obtain the desired level of effectiveness and safety of the inhaled drugs an appropriate deposition on the targeted region and subsequent absorption in the targeted region is vital Multiscale multidisciplin ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  9. A Novel, Microscale, Distributable Sensor Technology for Ionizing Radiation

    SBC: CFD Research Corporation            Topic: DTRA14B004

    Terrorist use of radioactive nuclear materials via nuclear and/or radiological dispersion devices (dirty bombs) is a serious threat. Therefore, it is critical to detect the proliferation of nuclear material. Critical challenges facing this objective include: (a) high sensitivity detection of signature emissions (e.g., gamma rays) from common radioactive isotopes behind shielding, and (b) cost-effe ...

    STTR Phase I 2015 Department of DefenseDefense Threat Reduction Agency
  10. Bionanomatrix coating for brain aneurysm coils to enhance healing

    SBC: ENDOMIMETICS, LLC            Topic: 105

    DESCRIPTION provided by applicant More than of the population has unruptured cerebral aneurysms approximately million people in the US About rupture per year with devastating consequences More than of patients with ruptured aneurysms die and of who survive have significant disabilities Detachable microcoils are now used in more than of treated aneurysms The risk ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government